| 30/03/2023 | Annual report 2022 |
| 22/03/2023 | Health economic model identifies GCAL® as a cost-effective biomarker |
| 17/03/2023 | Financial calendar |
| 16/02/2023 | Fourth quarter and full year 2022 report |
| 15/02/2023 | New study addresses the use of plasma calprotectin in sepsis management |
